Receptor Pharmacophore Ensemble (REPHARMBLE): a Probabilistic Pharmacophore Modeling Approach Using Multiple Protein-ligand Complexes
Overview
Authors
Affiliations
Ensemble methods are gaining more importance in structure-based approaches as single protein-ligand complexes strongly influence the outcomes of virtual screening. Structure-based pharmacophore modeling based on a single protein-ligand complex with complex feature combinations is often limited to certain chemical classes. The REPHARMBLE (receptor pharmacophore ensemble) approach presented here examines the ability of an ensemble of selected protein-ligand complexes to populate pharmacophore space in the ligand binding site, rigorously assesses the importance of pharmacophore features using Poisson statistic and information theory-based entropy calculations, and generates pharmacophore models with high probabilities. In addition, an ensemble scoring function that combines all the resultant high-scoring pharmacophore models to score molecules is derived. The REPHARMBLE approach was evaluated on ten DUD-E benchmark datasets and afforded good screening performance, as measured by receiver operating characteristic, enrichment factor and Güner-Henry score. Although one of the high-scoring models achieved superior statistical results in each dataset, the ensemble scoring function balanced the shortcomings of each model and passed with close performance measures. This approach offers a reliable way of choosing the best-scoring features to build four-feature pharmacophore queries and customize a target-biased 'pharmacophore ensemble' scoring function for subsequent virtual screening.
Zhang H, Qi H, Li Y, Shi X, Hu M, Chen X J Comput Aided Mol Des. 2024; 38(1):37.
PMID: 39528618 DOI: 10.1007/s10822-024-00580-2.
Qiu G, Yu L, Jia L, Cai Y, Chen Y, Jin J Mol Divers. 2024; 29(2):1353-1373.
PMID: 39009908 DOI: 10.1007/s11030-024-10918-5.
Tran X, Phan T, To V, Tran N, Nguyen N, Nguyen D Front Chem. 2024; 12:1382319.
PMID: 38690013 PMC: 11058650. DOI: 10.3389/fchem.2024.1382319.
Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches.
Hayat C, Subramaniyan V, Alamri M, Shing Wong L, Khalid A, Abdalla A BMC Chem. 2024; 18(1):76.
PMID: 38637900 PMC: 11027297. DOI: 10.1186/s13065-024-01178-3.
Christy H, Vasudevan S, Sudha S, Kandeel M, Subramanian K, Pugazhvendan S Biomed Res Int. 2022; 2022:6600403.
PMID: 35860806 PMC: 9293527. DOI: 10.1155/2022/6600403.